Terms: = Ovarian cancer AND Ki-67 AND Clinical Outcome
14 results:
1. Correlation of folate receptor alpha expression with clinicopathological parameters and outcome in triple negative breast cancer.
Zagorac I; Lončar B; Dmitrović B; Kralik K; Kovačević A
Ann Diagn Pathol; 2020 Oct; 48():151596. PubMed ID: 32829070
[TBL] [Abstract] [Full Text] [Related]
2. Single-stranded DNA binding protein 2 expression is associated with patient survival in hepatocellular carcinoma.
Kim H; Kim Y; Chung Y; Abdul R; Sim J; Ahn H; Shin SJ; Paik SS; Kim HJ; Jang K; Choi D
BMC Cancer; 2018 Dec; 18(1):1244. PubMed ID: 30541499
[TBL] [Abstract] [Full Text] [Related]
3. Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI.
Lindgren A; Anttila M; Rautiainen S; Arponen O; Kivelä A; Mäkinen P; Härmä K; Hämäläinen K; Kosma VM; Ylä-Herttuala S; Vanninen R; Sallinen H
Eur Radiol; 2017 Sep; 27(9):4002-4012. PubMed ID: 28289938
[TBL] [Abstract] [Full Text] [Related]
4. Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer.
Berntsson J; Lundgren S; Nodin B; Uhlén M; Gaber A; Jirström K
J Ovarian Res; 2014 Feb; 7():26. PubMed ID: 24568264
[TBL] [Abstract] [Full Text] [Related]
5. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
[TBL] [Abstract] [Full Text] [Related]
6. Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary.
Umezu T; Shibata K; Kajiyama H; Yamamoto E; Nawa A; Kikkawa F
J Clin Pathol; 2010 Nov; 63(11):962-6. PubMed ID: 20972242
[TBL] [Abstract] [Full Text] [Related]
7. Granulosa cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 21 cases.
Kondi-Pafiti A; Grapsa D; Kairi-Vassilatou E; Carvounis E; Hasiakos D; Kontogianni K; Fotiou S
Eur J Gynaecol Oncol; 2010; 31(1):94-8. PubMed ID: 20349790
[TBL] [Abstract] [Full Text] [Related]
8. EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
Kamat AA; Coffey D; Merritt WM; Nugent E; Urbauer D; Lin YG; Edwards C; Broaddus R; Coleman RL; Sood AK
Cancer; 2009 Jun; 115(12):2684-92. PubMed ID: 19396818
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
Tomsová M; Melichar B; Sedláková I; Steiner I
Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer.
Woenckhaus J; Steger K; Sturm K; Münstedt K; Franke FE; Fenic I
Virchows Arch; 2007 Apr; 450(4):387-95. PubMed ID: 17377809
[TBL] [Abstract] [Full Text] [Related]
11. Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential.
Nakayama K; Takebayashi Y; Hata K; Fujiwaki R; Iida K; Fukumoto M; Miyazaki K
Br J Cancer; 2004 Mar; 90(6):1204-10. PubMed ID: 15026802
[TBL] [Abstract] [Full Text] [Related]
12. Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome.
Abd-Elaziz M; Akahira J; Moriya T; Suzuki T; Yaegashi N; Sasano H
Cancer Sci; 2003 Nov; 94(11):980-5. PubMed ID: 14611675
[TBL] [Abstract] [Full Text] [Related]
13. Proliferative activity in primary ovarian carcinoid tumors.
Resl M; Reslová T; Krejcí E; Vagunda V; Nakatani Y; Miyagi E; Bedrna J; Richter P; Vorísek K
Gynecol Endocrinol; 2003 Feb; 17(1):1-6. PubMed ID: 12724012
[TBL] [Abstract] [Full Text] [Related]
14. Granulosa cell tumor of the ovary. Immunohistochemical evidence of low proliferative activity and virtual absence of mutation of the p53 tumor-suppressor gene.
Horny HP; Marx L; Kröber S; Lüttges J; Kaiserling E; Dietl J
Gynecol Obstet Invest; 1999; 47(2):133-8. PubMed ID: 9949285
[TBL] [Abstract] [Full Text] [Related]
